BiotechTube
Home/Mesenkia Therapeutics/Moa Fransson
MF

Moa Fransson

CEO

Mesenkia Therapeutics

Therapeutic Areas

OncologyNeuro-oncology

Mesenkia Therapeutics Pipeline

DrugIndicationPhase
HV01GlioblastomaPre-clinical

Leadership Team at Mesenkia Therapeutics

KM
Kohei Miyazono
Scientific Founder
CH
Carl-Henrik Heldin
Scientific Founder
BW
Bengt Westermark
Scientific Founder
CD
Cecilia Drakskog
Project Manager
LL
Liselotte Larsson
CMC Expert
View full Mesenkia Therapeutics profile